Page 2 of 3

The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

New publication on The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial from the American Heart Journal

The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

#vascularaccess #FOAMva #FOAMed #FOAMcc #FOAMus #FOAMrad #FOAMped #FOAMem

Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers

New publication on Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers from Transfusion and Apheresis Science

Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers

#vascularaccess #FOAMva #FOAMed #FOAMem #FOAMcc #FOAMems

5th World Congress for Vascular Access in Copenhagen

Come join Vascular Access Specialists from all around the globe at the 5th World Congress for Vascular Access, held in Copenhagen, Denmark from June 20th – 22nd.

Visit my page dedicated to the WoCoVA conference on my blogsite

flyer

Congress Information

Date

June 20 – 22, 2018

Location

Copenhagen, Denmark

Venue

Tivoli Hotel & Congress  Center
Arni Magnussons Gade 1 3
1577 Copenhagen
Denmark